Curtiss Wright Corp (CW) · Sep 14, 2026 · Other events
Buyback expanded — Total authorization increased to $700 million; $100 million plan through October 30
Curtiss-Wright adds $510 million to its buyback authorization and launches a $100 million 10b5-1 plan through October 30.
Curtiss-Wright is in a strong execution phase, supplying aerospace, defense, naval, and commercial-nuclear markets while raising its 2026 outlook and targeting $580–$600 million of free cash flow. Against that backdrop, this filing shifts more of that cash-generation story toward shareholder returns.
The headline is a materially larger capital-return pool. The board added $510 million to the repurchase authorization, taking total available capacity to $700 million. This is a genuine expansion rather than a routine confirmation, and it modestly strengthens the signal that management sees room to return cash while continuing to fund growth.
Near-term buying is more measured than the headline suggests. The company has committed to a $100 million Rule 10b5-1 plan running ratably through October 30, while the remaining authorization can be used later or not at all. That makes the immediate action meaningful but limited relative to the $700 million headline capacity.
This is capital allocation support, not a change to the operating strategy. Curtiss-Wright is still primarily building around defense demand, commercial aerospace, and nuclear growth; the filing adds no new operating target, acquisition, or guidance change. The company says repurchases are expected partly to offset employee-equity dilution, with discretionary purchases possible when conditions are attractive. 〔0〕
Bottom line: The event modestly improves the capital-return story and is better than simply maintaining the prior authorization, but it does not materially alter Curtiss-Wright’s underlying growth trajectory. The $100 million plan is the concrete near-term action; the rest is optional capacity.
10b5-1 plan expires October 30, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!